trial · primary record
JNJ-90301900
Carcinoma, Non-Small-Cell Lung
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 130 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Objective Response Rate (ORR) Using Independent Central Review (ICR) Assessment |
| Registry ID | NCT06667908 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.689Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06667908
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-90301900 · compound